Alterations in IRF1/IRF2 expression in acute myelogenous leukemia
โ Scribed by H.D. Preisler; S. Perambakam; B. Li; W.T. Hsu; P. Venugopal; S. Creech; S. Sivaraman; N. Tanaka
- Publisher
- John Wiley and Sons
- Year
- 2001
- Tongue
- English
- Weight
- 119 KB
- Volume
- 68
- Category
- Article
- ISSN
- 0361-8609
- DOI
- 10.1002/ajh.1144
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Abstract In patients with acute leukemia, Wilms' tumor gene 1 (WT1) has been used as a target for the detection of minimal residual disease (MRD) by PCR techniques. The expression of WT1 protein, however, has not been extensively studied. To determine the relation between expression of WT1 trans
Cytarabine and thioguanine therapy for acute myelomonocytic leukemia initiated in the tenth week of pregnancy (with the addition of vincristine and rubidomycin at 17 weeks) led to a short complete remission of the leukemia in a 24-year-old ptimigravida. This is the first case to be reported in which